Mutant epidermal growth factor (EGF) receptors (obtained by substitution of one, two or three C-terminal autophosphorylable tyrosine residues with phenylalanine residues or by deletion of the C-terminal 19 amino acids, including the distal tyrosine) were expressed in mouse NIH-3T3 fibroblast clones at densities comparable ( < 25 % difference) with those in control clones expressing the wild-type receptor. Total EGF-induced phosphorylation of the mutated receptors was not appreciably changed with respect to controls, whereas autophosphorylation at tyrosine residues was decreased, especially in the double and the triple mutants. In the latter mutant, expression of the EGFreceptor-activated lipolytic enzyme phospholipase Cy was unchanged, whereas its tyrosine phosphorylation induced by the growth factor was lowered to approx. 25 % of that in the controls. were approximately the same in all of the clones, whereas those induced by EGF were decreased in the mutants, again in proportion to the loss of the phosphorylable C-terminal tyrosine residues. The same trend occurred with membrane hyperpolarization, an effect secondary to the increase in [Ca2+]1 via the activation of Ca2+-dependent K+ channels. We conclude that C-terminal autophosphorylable tyrosine residues play a positive role in the regulation of transmembrane signalling at the EGF receptor. The stepwise decrease in signal generation observed in single, double and triple point mutants suggest that the role of phosphotyrosine residues is not in the participation in specific amino acid sequences, but rather in the introduction of strong negative charges at strategic sites of the receptor tail. As a consequence of autophosphorylation, the receptor could become competent for specific association with phospholipase Cy, with ensuing activation by tyrosine phosphorylation followed by the chains of intracellular responses ultimately leading to DNA synthesis and cell duplication.
INTRODUCTION
Extensive evidence demonstrates that, analogous to other growth factors, epidermal growth factor (EGF) has its effects via the activation of tyrosine kinase activity in the cytoplasmic domain of its receptor (EGFR) and the phosphorylation of specific intracellular substrates (for reviews see [1] [2] [3] [4] ). A few of these substrates have been identified, and some are recognized to be enzymes or enzyme regulators of fundamental importance in cellular control [5] [6] [7] [8] . Tyrosine phosphorylation is believed to modify the functioning of these molecules, thus initiating chain(s) of events which, in many cell types, ultimately lead to DNA replication and cell division. Among EGF substrates, one which has attracted a great deal of attention during the past few years is phospholipase Cy (PLCy), an enzyme mostly located in the soluble cytosol which, via the hydrolysis of phosphatidylinositol 4,5-bisphosphate, induces the generation of two well-known second messengers, inositol 1 ,4,5-trisphosphate and diacylglycerol [9] [10] [11] [12] [13] . The former messenger is known to activate release of Ca2l from intracellular rapidly-exchanging Ca2+ stores; the second activates protein kinase C [14] and, possibly, other important intracellular regulators [15] . Previous studies have already demonstrated that, in intact cells, a fraction of the PLCy molecules is physically bound to the EGFR to form a complex [9] [10] [11] [12] [13] , and that this complex is no longer formed when mutated, tyrosine kinase-incompetent, receptors are expressed. The phosphorylations necessary for receptor-enzyme association have recently been shown to reside in the EGFR C-terminal tail, i.e. to result from the process of autophosphorylation at residues 173,1148 and 1068 [16, 17] . Whether EGFR autophosphorylation is important for PLCy activation is, however, still unclear. In fact, when mutants of EGFR with their whole C-terminal tail deleted were studied [18, 19] , the increase in the free cytosolic Ca2+ concentration [Ca2+]1 induced by the growth factors (i.e. a consequence of PLCy activation) was found not to be inhibited, but rather to be slightly increased, provided that a short amino acid sequence (residues 973-991, more upstream of the autophosphorylation sites) was kept intact [19] . Large deletions, such as those investigated in the above studies, could however modify considerably the structure of the EGFR, and thus overwhelm unspecifically an autophosphorylation-relieved inhibitory regulation. In order to investigate this problem, we have now chosen to employ more subtle EGFR mutants, i.e. receptors either point-mutated in the three tyrosine residues or missing only the last few amino acids [20, 21] [20] . In some experiments a deletion mutant missing the distal 63 residues, including tyrosines 1173 and 1148 (Dc63), was employed [20] . Additional mutants were obtained by site-directed mutagenesis with substitution of tyrosine residues (YI 173, Y1 148 and Y1068) with phenylalanine [21] The results presented are representative of at least three separate experiments.
Membrane potential
Changes in membrane potential were studied using the slowresponse fluorescent dye bis-oxonol, as previously reported [29, 30] . Cell suspensions, prepared as described for removed and the monolayers were preincubated for 5 min in KRH, with 10 mM-LiCl replacing equimolar quantities of NaCl, after which EGF was added (10 nM). After 5 min, incubations were stopped by the addition of 2 ml of ice-cold 10 % trichloroacetic acid. In additional experiments, longer incubations (10 and 20 min) were used. Acid-treated dishes were placed on ice, and water-soluble radioactivity was extracted for 30 min. The whole supernatant was transferred to glass tubes and washed five times with 1 vol. of diethyl ether. Samples were brought to alkaline pH ( -8.5) by the addition of a small (50,ul) volume of 3 M-Tris, then ion-exchange resin was added to each sample, which was then washed eight times with 60 mmammonium formate/5 mM-disodium tetraborate (glycerophosphoinositol buffer). InsPs were eluted together by applying 3 ml of 1.7 M-ammonium formate, pH 3.7. A 2.5 ml portion of the supernatant was transferred to scintillation vials and counted for radioactivity after mixing with 16 ml of Packard Hionicfluor. For additional detail, see [29] .
Materials
Serum and culture media were from Flow Laboratories; myo-[3H]inositol from Amersham International; EGF (receptor grade) and fibroblast growth factor (FGF) from BoehringerMannheim; fura-2 from Calbiochem; and bis-oxonol from Molecular Probes. Other chemicals were reagent grade, supplied by the sources indicated previously [29, 30] .
RESULTS
Fig . 1 illustrates the various NIH-3T3 clones employed in this work. The deletion mutant Dcl9 was engineered in order to remove the distal EGFR tyrosine autophosphorylation site located in the receptor tail, as well as the surrounding amino acids. In a few experiments another deletion mutant (Dc63, missing the two distal tyrosine residues; receptor density 1.3 x 105/cell) was also employed [20] . Point mutants were obtained by substitution with phenylalanine residues of one (F1173), two [25] ) was very similar in the two clones, whereas the concentration of EGFR (measured by the same technique) was distinctly greater in the mutant, consistent with the data of Fig. 1 . In contrast, the EGF-induced tyrosine phosphorylation of the lipolytic enzyme was markedly higher in the wild-type pCOI1 clone (Fig. 3a) . Accurate densitometry of these data revealed the phosphotyrosine-positive fraction of PLCy, normalized on the basis of EGFR expression, to be decreased in the mutant-EGFR-bearing clone to -25 % of that in the wild-type clone (Fig. 3d ). receptors were even more pronounced (Fig. 4) Figs. 5(a) and 6, the 5 demonstrated that these decreases were not so much due to a loss of EGF potency, but rather to a marked decrease in EGF efficacy.
Results similar to those of [Ca2l], were obtained also by investigating the effect of EGF on membrane potential. The large hyperpolarization induced in the clones expressing the wild-type EGFR (due to the activation of Ca2+-dependent K+ channels [29] ) was in fact decreased in those cells expressing the mutant receptors (Fig. 7) , in parallel with the decreased [Ca2+] responses. Again, no substantial difference between the Dcl9 deletion and the corresponding F1 173 point mutant was observed.
DISCUSSION
The present work was carried out to investigate whether, and to what extent, the C-terminal autophosphorylation sites of the EGFR control the process of activation of PLCy, a substrate of the EGFR tyrosine kinase. Recently, two reports have appeared implicating the autophosphorylation process as a positive regulator of the physical association between the EGFR and the lipolytic enzyme [16, 17] , but the precise role of the various tyrosine residues involved (at positions 1173, 1168 and 1048) and of the adjacent amino acid sequences was not established. Moreover, the only activity data available (concerning, however, not directly the enzyme-catalysed reaction, but one of its consequences, the increase in [Ca2+], in EGF-treated cells) were in apparent contrast with those on the EGFR-PLCy association. In fact, in cells expressing EGFRs with the C-terminal tail deleted up to residue 991, the EGF-induced response was found to be increased, and not decreased, relative to the controls [19] . Taken together with the previous data on the EGFR-PLCy The reported disagreement between the association and activity data discussed above [16, 17, 19] may have been only apparent, for two possible reasons. Large deletions of the C-terminal tail, such as those investigated by Chen et al. [19] , could have modified unspecifically the process of enzyme-substrate interaction, in particular by eliminating the link between association and phosphorylation which may exist between the intact EGFR and the enzyme. Moreover, the activity studies of Chen et al. [19] were carried out with a mutated cell clone expressing almost twice as many EGFRs as the control, wild-type clone. We and others [34, 37] In order to cope with these problems, on the one hand we have employed NIH-3T3 fibroblasts expressing mutated EGFRs only slightly different from the wild-type receptor (substitution of one, two or three tyrosine with phenylalanine residues or small deletions); on the other hand, the mutated clones were chosen based on their EGFR density, which was close ( < 25 % difference) to that of a wild-type clone (see Fig. 1 ). Experimentalto-control comparisons could thus not be affected by major differences in receptor expression. However, receptor expression is not the only property of the clones that can, at least in principle, become limiting in the generation of physiological responses. Among other at least potentially important properties we can list the PLCy and phosphatidylinositol 4,5-bisphosphate content of the cells, the density of InsP3 receptors and plasma membrane channels (both cation-and K+/Ca2+-dependent channels) activated on EGF treatment, and the size of the rapidly exchanging intracellular Ca2+ pool(s). The PLCy content was investigated directly by Western blotting in the wild-type and in the triple-mutated clones, and was found to be very similar in both. This is in contrast with EGF-induced tyrosine phosphorylation, which was drastically decreased in the mutant. With the other clones no direct evidence is available, and the same is true for the other properties listed above. It should be mentioned, however, that all the clones investigated responded in a similar fashion to the controls when treated with other agents (i.e. FCS and FGF) which are known to activate the investigated responses by the same general mechanisms as does EGF, and which were employed as controls for phosphoinositide hydrolysis and [Ca2+]1.
We conclude that the general responsiveness of the various clones was similar to the control, and that the differences observed with EGF were due, at least primarily, to the mutations in the EGFR C-terminal tail.
The [18, 31] . With regard to the mechanism by which mutations affect EGFR functioning, previous studies with our various mutants had revealed no changes in their affinity for EGF [20, 21] . This result is in agreement with the present observation that the apparent potency of the growth factor was essentially unchanged, while its efficacy was decreased. Moreover, the stepwise increase in inhibition observed with our single, double and triple mutants suggests that the various tyrosine residues play similar roles, i.e. they are not important as the members of specific amino acid sequences, but, after phosphorylation, they confer to the Cterminal tail strong strategically located negative charges that might be needed to open the access of PLCy to a specific binding site. The latter would be responsible for the association of PLCy with the EGFR, envisaged as a preliminary step in the process of phosphorylation (see also [16, 17] ). This conclusion appears to be consistent with recently reported results on a phosphorylated EGFR C-terminal peptide which was found to compete with the entire receptor for PLCy binding [17] . The sequence in the EGFR tail that functions as the binding site for PLCy has not yet been identified. Our data with the deletion mutant seem to exclude the distal 19 amino acids, and preliminary results with a mutant lacking the 63 distal amino acids seem to exclude the additional sequence as well. A possible candidate is the EGFR (973-991)-peptide reported by Chen et al. [19] to be needed for eliciting responses in [Ca2l] , in cells expressing largely deleted EGFR. This possibility, however, remains to be investigated.
PLCy is not the only EGFR substrate known to associate with the receptor to form a complex. This has also been reported for the GTPase-activating protein of the ras proto-oncogene (GAP) and for a few other proteins, all endowed with similar sequences (denominated SH2 and SH3) which are thought to participate in the complex formation [1, 2, 7, 8, 17] . Thus it seems likely that the positive role of autophosphorylation that we have described here exists not only for the lipolytic enzyme but for other EGFR substrates as well. Moreover, a similar situation could exist at other growth factor receptors which are also endowed with both intrinsic tyrosine kinase activity and autophosphorylated tyrosine residues. Because of this possible wide-ranging application, the so far largely unexplored role of the EGF receptor C-terminal tail in cell physiology deserves further investigation.
